Medicover enters UK market, plans expansion in Poland

Medicover, a health care company, has finalized the acquisition of a majority stake in Reproductive Health Group (RHG), a British center for treating infertility, the company announced in a press release. The company expects to double its revenue from treating infertility and hopes it will account for 10 percent of its total revenues in 2018. Medicover said that the infertility treatment is one of the priority areas of Medicover's planned investments both in Poland and in other European markets. Medicover already has five clinics specializing in infertility treatment in our country; these operate under the brand InviMed. "We are currently in the process of identification of regions in Poland, where access to infertility treatment is not sufficient. We plan to open more InviMed clinics in such places. This way, we plan to strengthen our position as a leader in the field of infertility treatment in Poland," said John Stubbington, COO of Medicover Group.